Sobior Swedish Orphan Biovitrum Abis A Public Biopharmaceutical Company Based In Stockholmswedenit Is Listed On The Nasdaq Stockholm Under The Ticker Symbol Sobithe Company Specializes In Developing Treatments For Rare And Debilitating Diseaseswith A Focus On Haematologyimmunologyand Specialty Caresobi Aims To Improve The Lives Of Individuals With Rare Diseases Through Its Innovative Products And Services Sobi S Product Portfolio Includes Treatments For Conditions Such As Hemophiliaimmunology Disordersand Amyotrophic Lateral Sclerosisals The Company Is Actively Involved In Over 150 Clinical Trialsemphasizing Its Commitment To Research And Development In Its Therapeutic Areaswith A Presence In Europethe Middle Eastnorth Americarussiaand Asiasobi Serves A Diverse Global Customer Baseincluding Healthcare Providers And Organizations Dedicated To Treating Rare Diseasesin 2022Sobi Reported A Revenue Of Sek 18 8 Billion And Employed Approximately 1 600 People
No conferences found for this company.
| Company Name | Swedish Orphan Biovitrum As |
| Country |
Norway
|
| Address | N/A |
| Telephone | N/A |
| N/A |
